1. Home
  2. ATCH vs CCEL Comparison

ATCH vs CCEL Comparison

Compare ATCH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.25

Market Cap

39.2M

Sector

N/A

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.44

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
CCEL
Founded
2022
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.2M
32.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
ATCH
CCEL
Price
$0.25
$3.44
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
4.2M
4.1K
Earning Date
02-18-2026
10-15-2025
Dividend Yield
N/A
11.63%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,303,120.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
80.78
N/A
52 Week Low
$0.14
$3.19
52 Week High
$15.27
$8.79

Technical Indicators

Market Signals
Indicator
ATCH
CCEL
Relative Strength Index (RSI) 34.35 38.12
Support Level $0.25 $3.58
Resistance Level $0.27 $3.99
Average True Range (ATR) 0.02 0.24
MACD -0.00 -0.03
Stochastic Oscillator 0.89 26.02

Price Performance

Historical Comparison
ATCH
CCEL

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: